Press release
Tremfya Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends
Tremfya
The increasing prevalence of autoimmune diseases is expected to propel the growth of the Tremfya market going forward. Autoimmune diseases refer to conditions in which the body's immune system mistakenly attacks its cells, tissues, or organs, perceiving them as foreign invaders. The increasing prevalence of autoimmune diseases is due to genetic predisposition, environmental triggers, lifestyle changes, increased awareness, and improved diagnostic capabilities. Tremfya is a monoclonal antibody targeting interleukin-23 (IL-23) that helps manage autoimmune diseases by modulating the immune system's overactive response, reducing inflammation, and alleviating symptoms in conditions such as psoriasis and psoriatic arthritis. For instance, in June 2024, according to a report published by the Australian Institute of Health and Welfare, an Australian-based governmental organization, in 2022, there were 10,000 hospitalizations for rheumatoid arthritis, marking a 25% increase from 8,000 in the previous year, with a hospitalization rate of 39 per 100,000 people. Therefore, the increasing prevalence of autoimmune diseases is driving the growth of the Tremfya market.
Get Your Tremfya Market Report Here:
https://www.thebusinessresearchcompany.com/report/tremfya-global-market-report
What is the projected compound annual growth rate (CAGR) of the tremfya market from 2025 to 2034, and what factors influence it?
The Tremfya market size has seen XX (HCAGR) in recent years. It will rise from $XX million in 2024 to $XX million in 2025, at a compound annual growth rate (CAGR) of XX%. The growth in the historic period is attributed to the increasing prevalence of psoriasis and psoriatic arthritis, a greater focus on targeted therapies, rising healthcare investments, a growing number of specialty clinics, and the increasing adoption of biologics in dermatology and rheumatology.
The Tremfya market size is projected to reach $XX million by 2029 at a CAGR of XX%. Growth drivers include increasing healthcare infrastructure, the rising adoption of point-of-care testing, growing investment in healthcare research, and a growing focus on precision medicine. Trends in the forecast period include advancements in treatment modalities, personalized medicine approaches, technological integration in patient monitoring, the rise of AI in healthcare, and improvements in injection devices.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20343&type=smp
How are the latest trends influencing the growth of the tremfya market?
A significant development in the Tremfya market is obtaining official approvals to increase its therapeutic indications like for moderate-to-severe Crohn's disease. This step enhances its potential patient pool and market scope. Regulatory approvals are endorsements given by organizations like the FDA or EMA, permitting the marketing of a drug for particular uses post-proving its safety, effectiveness, and quality. As an illustration, in September 2024, Johnson & Johnson, a pharmaceutical company based in the US, got FDA's nod for Tremfya (guselkumab) to treat adults with moderately to severely active ulcerative colitis, making it the first-ever dual-acting interleukin-23 inhibitor approved for such a condition. This approval owes its credit to the positive findings from the Phase 2b/3 QUASAR study, which revealed that almost half of the patients accomplished clinical remission post 44 weeks of therapy. Tremfya takes aim at interleukin-23, which aids in normalizing the inflammation response in the colon.
What are the major segments of the tremfya market and their role in driving growth?
The tremfya market covered in this report is segmented -
1) By Indication: Moderate-To-Severe Plaque Psoriasis; Active PsA
2) By Formulation: Subcutaneous Injection; Intravenous Infusion
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
4) By End User: Adult Patients; Geriatric Patients
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20343
Which regions are key players in the growth of the tremfya market?
North America was the largest region in the tremfy market in 2024. The regions covered in the tremfya market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the tremfya market?
Major companies operating in the tremfya market are Johnson & Johnson
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20343&type=smp
What Is Covered In The Tremfya Global Market Report?
•Market Size Forecast: Examine the tremfya market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the tremfya market for a structured understanding.
•Key Players Overview: Analyze major players in the tremfya market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the tremfya market.
•Segment Contributions: Evaluate how different segments drive overall growth in the tremfya market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the tremfya market.
•Industry Challenges: Identify potential risks and obstacles affecting the tremfya market.
•Competitive Landscape: Review strategic developments in the tremfya market, including expansions, agreements, and new product launches.
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tremfya Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here
News-ID: 3943548 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Tremfya
Tremfya Industry Report 2025-2034: Market Dynamics, Drivers, And Forecasts
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Tremfya Market?
In more recent times, the market size for Tremfya has experienced a growth of XX (HCAGR). There is an expected increase from $XX million in 2024 to $XX million in 2025, reflecting a compound annual growth rate (CAGR) of XX%. Factors that have…
Tremfya Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emer …
What combination of drivers is leading to accelerated growth in the tremfya market?
The increasing prevalence of autoimmune diseases is expected to propel the growth of the Tremfya market going forward. Autoimmune diseases refer to conditions in which the body's immune system mistakenly attacks its cells, tissues, or organs, perceiving them as foreign invaders. The increasing prevalence of autoimmune diseases is due to genetic predisposition, environmental triggers, lifestyle changes, increased awareness,…
Ulcerative Colitis Clinical Pipeline | 70+ Companies Pioneering the Next Breakth …
The ulcerative colitis market is undergoing a transformative shift, driven by cutting-edge research and innovative therapies.
DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline Ulcerative Colitis therapies in various stages of clinical development. Major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Ulcerative Colitis pipeline domain.
For Ulcerative Colitis emerging drugs, the Ulcerative Colitis pipeline analysis report provides a…
Giant-Cell Arteritis Market to witness growth by 2034, estimates DelveInsight | …
Giant-Cell Arteritis companies are AbbVie, CSL, Kiniksa Pharmaceuticals, Dr Reddys Laboratories, Eli Lilly and Company, Janssen Biotech, Johnson & Johnson, Kiniksa Pharmaceuticals, Ltd., MorphoSys AG, Novartis Pharmaceuticals, Roche Holding, XOMA, and several others.
(Albany, USA) DelveInsight's "Giant-Cell Arteritis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Giant-Cell Arteritis, historical and forecasted epidemiology as well as the Giant-Cell Arteritis market trends in the United States, EU5 (Germany, Spain,…
Inflammatory Bowel Disease Market is Projected to Grow during the Study Period ( …
(Albany, USA) DelveInsight's "Inflammatory Bowel Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Inflammatory Bowel Disease, historical and forecasted epidemiology as well as the Inflammatory Bowel Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Inflammatory Bowel Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current…
Immunology Market to Witness Huge Growth by 2026 | Leading Key Players AbbVie In …
According to a report published by Fortune Business Insights, titled “IMMUNOLOGY Market Size, Share and Global Trend By Drug Class ( Monoclonal antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal antibody (pAb), Others ), By Disease Indication ( Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others ), By Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography Forecast till 2026: GLOBAL MARKET…
